Information on the target
Tjoapack is a prominent global contract packaging organization specializing in the pharmaceutical and biotechnology sectors. Established in 1989, the company has developed a robust reputation for delivering innovative and flexible packaging solutions across five continents and in 45 countries. With a state-of-the-art facility spanning 120,000 square feet, strategically located near the ports of Rotterdam and Antwerp, Tjoapack is well-positioned to serve the European market effectively. The company operates 19 packaging lines, offering a comprehensive range of services, including primary, secondary, and unit dose packaging for oral solid dose blister packs, wallets, and bottles, as well as automated labeling and packaging for injectable products.
Industry overview in the target’s specific country
The Non-Paper Containers & Packaging (NEC) industry in the Netherlands has experienced significant growth, driven by increasing demand for sustainable and innovative packaging solutions. As a key player in the European market, the Netherlands benefits from its strategic location, advanced logistics infrastructure, and a strong emphasis on research and development. The industry is characterized by a diverse range of materials, including plastics, metals, and glass, which are increasingly being utilized to meet the evolving needs of consumers and businesses alike.
In recent years, the Dutch government has implemented stringent regulations aimed at reducing plastic waste and promoting circular economy practices. This has led to a surge in investments in eco-friendly packaging alternatives, positioning the Netherlands as a leader in sustainable packaging solutions. Companies within the Non-Paper Containers & Packaging sector are actively exploring innovative materials and technologies to enhance product functionality while minimizing environmental impact.
Furthermore, the rise of e-commerce and the growing demand for convenience-driven packaging have further fueled the expansion of the Non-Paper Containers & Packaging industry in the Netherlands. As consumer preferences shift towards online shopping and ready-to-use products, packaging solutions that ensure product integrity and enhance user experience are becoming increasingly vital. This trend is expected to continue, providing ample opportunities for growth and innovation within the sector.
The rationale behind the deal
The sale of Tjoapack to Alcami Corporation represents a strategic alignment that enhances both companies' capabilities in the pharmaceutical packaging space. Ampersand Capital Partners, having invested in Tjoapack in 2020, successfully guided the company through a transformative growth phase, expanding its operations into the U.S. market and enhancing its service offerings. The partnership with Alcami is a logical progression, allowing Tjoapack to leverage Alcami's extensive resources and expertise in contract development and manufacturing, thereby creating a more comprehensive service platform for clients.
Information about the investor Ampersand Capital Partners is a middle-market private equity firm founded in 1988, with a focus on growth-oriented investments in the healthcare sector. With approximately $3 billion in assets under management, Ampersand has established a strong presence in key markets, including Boston, Amsterdam, and L…